clofarabine (Clolar)

Tradename: Clolar (FDA-approved in 2004) Indications: - pediatric acute lymphoblastic leukemia, relapsed or refractory periods Notes: Manufacturer: Genzyme

General

purine antimetabolite; antimetabolite; purine analog antineoplastic agent (chemotherapeutic agent)

References

Prescriber's Letter 12(2): 2005 New Drugs Approved by the FDA in 2004 Detail-Document#: 210216 (subscription needed) http://www.prescribersletter.com